118th Congress · SENATE BILLBILL

S. 1544Facilitating Innovative Nuclear Diagnostics Act of 2023

A bill to amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, diagnostic radiopharmaceuticals under the Medicare hospital outpatient prospective payment system.

Health
Introduced May 10, 2023
Last action May 10, 2023
Pipeline · Bill → Law
Step 1
Introduced
May 10, 2023
Step 2
Referred
May 10, 2023
Finance
Step 3
Committee
Step 4
Senate
Step 5
House floor
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.

Provisions · 2 sectionsIntroduced in Senate
Timeline · 2 actions
May 10, 2023
Introduced in Senate
May 10, 2023
Read twice and referred to the Committee on Finance.